26,90 €
1,47 % gestern
L&S, 6. Oktober, 22:54 Uhr
ISIN
US52490G1022
Symbol
LEGN
Berichte

Legend Biotech Corp - ADR Aktie News

Positiv
Seeking Alpha
etwa 7 Stunden alt
While AI hype reigns on Wall Street, the healthcare sector is still far from the peaks it reached during the COVID-19 pandemic. And what's more important, many of the biotech stocks remain outside of Mr. Market's interest zone. Since the exclusivity of key blockbusters of 'giants', including Merck and Pfizer, expires in the next 4 years, there is an urgent need to continue rejuvenating their po...
Neutral
Seeking Alpha
27 Tage alt
Legend Biotech Corporation (NASDAQ:LEGN ) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 4:05 PM EDT Company Participants Ying Huang - CEO & Director Conference Call Participants Terence Flynn - Morgan Stanley, Research Division Presentation Terence Flynn Equity Analyst Great. Thanks for joining us, everybody.
Neutral
GlobeNewsWire
etwa 2 Monate alt
SOMERSET, N.J., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced the appointment of Carlos Santos as the Company's Chief Financial Officer, effective immediately. Mr. Santos assumes the role from Jessie Yeung, who has served as the interim CFO since January 2025.
Neutral
Seeking Alpha
etwa 2 Monate alt
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
Neutral
Seeking Alpha
etwa 2 Monate alt
New Jersey based Legend Biotech announced its Q2 earnings on Monday, reporting $439m of revenues for its only commercial product, the cell therapy Carvykti. Carvykti leads CAR-T therapy sales with strong efficacy and double-digit sequential revenue growth, but Legend only receives a 50% revenue share outside China. Despite >$1bn cash and operational improvements, Legend remains unprofitable, wi...
Neutral
Seeking Alpha
etwa 2 Monate alt
Legend Biotech Corporation (NASDAQ:LEGN ) Q2 2025 Earnings Conference Call August 11, 2025 8:00 AM ET Company Participants Alan S. Bash - President of CARVYKTI® Caroline LeCates Paul - Associate Director of Investor Relations Jessie Yeung - Interim CFO, Principal Financial Officer & Principal Accounting Officer Mythili Koneru - Chief Medical Officer Ying Huang - CEO & Director Conference Call P...
Neutral
GlobeNewsWire
etwa 2 Monate alt
SOMERSET, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today reported its second quarter 2025 unaudited financial results and key corporate highlights.
Negativ
Investors Business Daily
4 Monate alt
The latest shake-up at the FDA forced out the top two officials in charge of reviewing cell and gene therapies, analysts said.

Kostenlos registrieren

aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.

Die Apple Aktie im Überblick mit Charts, aktuellen Kennzahlen, Nachrichten und Aktienanalysen.
Die besten Dividenden-Aktien in der Dividenden-Topscorer-Liste.
Aktienanalysen der besten Aktien weltweit.
Jetzt Vermögen aufbauen